1,243
Views
17
CrossRef citations to date
0
Altmetric
Research Article

Evaluation of the analgesic activities of the crude aqueous extract and fractions of Shao Fu Zhu Yu decoction

, , , , , & show all
Pages 137-145 | Received 07 Nov 2009, Accepted 26 Jun 2010, Published online: 13 Oct 2010

References

  • Alkerlund M. (1979). Pathophysiology of dysmenorrhea. Acta Obstet Gynecol Scand, 87, 27–32.
  • al-Swayeh OA, Clifford RH, del Soldato P, Moore PK. (2000). A comparison of the anti-inflammatory and anti-nociceptive activity of nitroaspirin and aspirin. Br J Pharmacol, 129, 343–350.
  • Chien TY, Chen LG, Lee CJ, Lee FY, Wang CC. (2008). Anti-inflammatory constituents of Zingiber zerumbet. Food Chem, 110, 584–589.
  • Dawood MY, Khan-Dawood FS. (2007). Differential suppression of menstrual fluid prostaglandin F2a, prostaglandin E2, 6-keto prostaglandin F1a and thromboxane B2 by suprofen in women with primary dysmenorrhea. Prostaglandins Other Lipid Mediat, 83, 146–153.
  • Du JR, Yu Y, Ke Y, Wang CY, Zhu L, Qian ZM. (2007). Ligustilide attenuates pain behavior induced by acetic acid or formalin. J Ethnopharmacol, 112, 211–214.
  • Harada T, Takahashi H, Kaya H, Inoki R. (1979). A test for analgesics as an indicator of locomotor activity in writhing mice. Arch Int Pharmacodyn Ther, 242, 273–284.
  • Hsia SM, Kuo YH, Chiang W, Wang PS. (2008). Effects of adlay hull extracts on uterine contraction and Ca2+ mobilization in the rat. Am J Physiol Endocrinol Metab, 295, 719–726.
  • Lantz RC, Chen GJ, Sarihan M. (2007). The effect of extracts from ginger rhizome on inflammatory mediator production. Phytomedicine, 14, 123–128.
  • Li QZ. (2006). An analysis on the main type of syndrome in TCM and the factors affecting primary dysmenorrheal in adolescent girls. J Emerg TCM, 15, 996–997.
  • Lumsden MA, Kelly RW, Baird DT. (1983). Primary dysmenorrhoea: The importance of both prostaglandins E2 and F2 alpha. Br J Obstet Gynaecol, 90, 1135–1140.
  • Ma HY, Kou JP, Wang JR, Yu BY. (2007). Evaluation of the anti-inflammatory and analgesic activities of Liu-Shen-Wan and its individual fractions. J Ethnopharmacol, 112, 108–114.
  • Malmberg AB, Yaksh TL. (1992). Antinociceptive actions of spinal nonsteroidal anti-inflammatory agents on the formalin test in the rat. J Pharmacol Exp Ther, 263, 136–146.
  • Mesiano S, Welsh TN. (2007). Steroid hormone control of myometrial contractility and parturition. Semin Cell Dev Biol, 18, 321–331.
  • National Research Council. (1996). Guide for the Care and Use of Laboratory Animals. Washington DC, USA: National Academy Press.
  • Nissenson R, Flouret G, Hechter O. (1978). Physiological sciences opposing effects of estradiol and progesterone on oxytocin receptors in rabbit uterus. Proc Natl Acad Sci USA, 4, 2044–2048.
  • Rainsford KD. (2006). Current status of the therapeutic uses and actions of the preferential cyclo-oxygenase-2 NSAID, nimesulide. Inflammopharmacology, 14, 120–137.
  • Ruttner Z, Ivanics T, Slaaf DW, Reneman RS, Toth A, Ligeti L. (2002). In vivo monitoring of intracellular free calcium changes during uterine activation by prostaglandin F2 alpha and oxytocin. J Soc Gynecol Investig, 9, 294–298.
  • Santos AR, Vedana EM, De Freitas GA. (1998). Antinociceptive effect of meloxicam in neurogenic and inflammatory nociceptive models in mice. Inflamm Res, 47, 302–307.
  • Sayyah M, Hadidi N, Kamalinejad M. (2004). Analgesic and anti-inflammatory activity of Lactuca sativa seed extract in rats. J Ethnopharmacol, 92, 325–329.
  • Su SL, Hua YQ, Duan JA, Tang YP, Lu Y, Ding AW. (2007). In vitro inhibition on the contraction of isolated mouse uterine and chemical components of Shaofu Zhuyu decoction. J China Pharm Univ, 38, 544–548.
  • Su SL, Duan JA,Wang TJ, Yu L, Hua YQ, Tang YP. (2008). Evaluating the effects of Shaofu Zhuyu decoction on hemorheology and ovarian function in rat model of Han-ning blood stasis. Ch J Exp Trad Med Form, 14, 41–43.
  • Sugimoto M, Kuraishi Y, Satoh M, Takagi H. (1986). Involvement of medullary opioid-peptidergic and spinal noradrenergic systems in the regulation of formalin-induced persistent pain. Neuropharmacology, 25, 481–485.
  • Sun HY, Cao YX, Liu J, Gao JW, Ma M. (2002). The establishment of the dysmenorrhea model in mice. Ch Pharm Bull, 18, 233–236.
  • Sun Y, Dong Y, Jiang HJ, Cai TT, Chen L, Zhou X, Chen T, Xu Q. (2009). Dissection of the role of paeoniflorin in the traditional Chinese medicinal formula Si-Ni-San against contact dermatitis in mice. Life Sci, 84, 337–344.
  • Tasaka K, Masumoto N, Miyake A, Tanizawa O. (1991). Direct measurement of intracellular free calcium in cultured human puerperal myometrial cells stimulated by oxytocin: Effects of extracellular calcium and calcium channel blockers. Obstet Gynecol, 77, 101–106.
  • Tognolini M, Barocelli E, Ballabeni V, Bruni R, Bianch A. (2006). Comparative screening of plant essential oils: Phenylpropanoid moiety as basic core for antiplatelet activity. Life Sci, 78, 1419–1432.
  • Tsai TY, Wu SN, Liu YC, Wu AZ, Tsai YC. (2005). Inhibitory action of L-type Ca2+ current by paeoniflorin, a major constituent of peony root, in NG108-15 neuronal cells. Eur J Pharmacol, 523, 16–24.
  • van Eick AJ. (1967). A change in the response of the mouse in the “hot plate” analgesia-test, owing to a central action of atropine and related compounds. Acta Physiol Pharmacol Neerl, 14, 499–500.
  • Wiener E, Levanon D. (1968). The in vitro interaction between bacterial lipopolysaccharide and differentiating monocytes. Lab Invest, 19, 584–590.
  • Wu D, Mura C, Beharka AA, Han SN, Paulson KE, Hwang D, Meydani SN. (1998). Age-associated increase in PGE2 synthesis and COX activity in murine macrophages is reversed by vitamin E. Am J Physiol, 275, 661–668.
  • Zhang XJ, Li Z, Leung WM, Liu L, Xu HX, Bian ZX. (2008). Analgesic effect of paeoniflorin on maternal separation induced visceral hyperalgesia in rats. J Pain, 9, 497–505.
  • Zhang XL. (1987). Clinic applications of Shao-Fu-Zhu-Yu decoction. Hebei J TCM, 3, 18.
  • Zhang XM. (1992). Progress of the treatment in dysmenorrhoea with traditional Chinese medicine. Ch J Pract Ch Mod Med, 5, 423–425.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.